Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Hagens Berman Alleges Fraud and Corruption in AstraZeneca AZN; Shares Plummet

December 14, 2024
Leading law firm Hagens Berman has initiated an investigation into British pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) following reports of potential fraud and corruption within the company. The allegations claim that AstraZeneca has been involved in unethical practices, including bribery and data manipulation, which has raised concerns among investors and regulatory authorities alike. As a result, the company's shares have taken a significant hit, plummeting by X% in a single day of trading.

AstraZeneca, a renowned player in the global pharmaceutical industry, has consistently been considered a top value stock for long-term investors. However, these recent allegations have cast a shadow of doubt over the company's integrity and future prospects. Investors are now concerned about potential legal repercussions and the impact these allegations may have on AstraZeneca's overall financial performance.

In light of these developments, stock market experts at Stocks Prognosis recommend seeking professional guidance before making any investment decisions regarding AstraZeneca's stocks. Consulting these seasoned professionals will provide investors with a comprehensive analysis of the current situation, allowing them to make informed choices about the future movement of AstraZeneca's shares.

Disclaimer: This news article does not offer or promote the sale or purchase of AstraZeneca PLC's stocks.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNJune 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know  ~1 min.

AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....


AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....


AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....


AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....


AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....


AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....


AZNMarch 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy  ~2 min.

ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....


AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....


AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....


AZNFebruary 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....


AZNDecember 24, 2024AstraZeneca: Shares Drop Amidst Reports of PRC Investigation  ~1 min.

AstraZeneca PLC, a leading pharmaceutical company, saw a decline in its shares following reports of a probe initiated by the People's Republic of China (PRC)....


AZNNovember 4, 2024Investors Should Know: AstraZeneca AZN Rises, But Trails Market  ~1 min.

Recently, pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) has seen its stock price rise, but not at the same pace as the overall market....


AZNDecember 13, 2024Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000....


AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....


AstraZeneca PLC (AZN): A Rising Star in the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....